Long non‑coding RNAs (lncRNAs) have been revealed to have a marked effect in
cardiovascular diseases, including during cardiac development, cardiac hypertrophy …

The regulatory role of long noncoding RNA (lncRNA) growth arrest-specific transcript 5
(GAS5) in both cancerous and noncancerous cells have been widely reported. This study …

OBJECTIVE: The aim of this study was to investigate the effect of long non-coding
ribonucleic acid (lncRNA) growth arrest specific 5 (GAS5) on acute myocardial infarction …

Long noncoding RNAs (lncRNAs) play critical roles in the pathogenesis of cardiovascular
diseases, especially in myocardial infarction (MI). However, the underlying molecular …

Growth arrest‐specific transcript 5 (GAS5), along non‐coding RNA (LncRNA), is highly
expressed in hypoxia/reoxygenation (H/R)‐cardiomyocytes and promotes H/R‐induced …

We carefully read with interest the recent article by Zhao et al.[1] concerning “Circulating
Serpina3 levels predict the major adverse cardiac events in patients with myocardial …

It has been reported that lncRNA GAS5 can inhibit LPS-induced inflammation, indicating its
involvement in sepsis. We observed the downregulation of GAS5 in plasma of sepsis …

The present study was designed to investigate whether and how lncRNA-GAS5 regulates
cardiomyocyte apoptosis in MI. MI rat model was established by the left anterior descending …

Objective: Diabetic cardiomyopathy (DCM) is one of the complications experienced by
patients with diabetes. In recent years, long noncoding RNAs (lncRNAs) have been …

Long noncoding RNA GAS5 is down-regulated in cardiomyocytes in diabetic
cardiomyopathy (DCM). Here, we studied the involvement of GAS5 in DCM by analyzing its …